Published in Eur J Clin Pharmacol on January 01, 1994
Orlistat associated with hypertension. BMJ (2000) 1.49
Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J Pediatr Endocrinol Metab (2004) 0.96
Present and future: pharmacologic treatment of obesity. J Obes (2011) 0.84
Tackling obesity: new therapeutic agents for assisted weight loss. Diabetes Metab Syndr Obes (2010) 0.76
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet (1998) 6.17
Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess (2004) 5.31
Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin. Lancet (1994) 3.72
Cerebral function in diabetes mellitus. Diabetologia (1994) 2.82
A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N Engl J Med (1998) 2.42
[Finnish descendants in the municipality of Sor-Varanger--II. An investigation of blood pressure, height, weight, cholesterol, triglycerides and lipoproteins among Finnish descendant men--and the effect of a diet change]. Tidsskr Nor Laegeforen (1974) 2.33
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation (2000) 2.19
Compatibility of insulin pens and cartridges. Lancet (1997) 2.13
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet (2001) 2.08
Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading. Diabetes (1976) 2.04
[Psychiatric drugs as risk factor in fatal heat stroke]. Ned Tijdschr Geneeskd (1995) 2.03
[Familial combined hyperlipidemia]. Ned Tijdschr Geneeskd (1996) 2.03
[Statins: possibly more than just lowering of the lipid level]. Ned Tijdschr Geneeskd (2000) 1.97
Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1987) 1.96
Open questions about metabolically normal obesity. Int J Obes (Lond) (2010) 1.83
Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res (1998) 1.79
Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism (1982) 1.79
Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes (1987) 1.76
Partial remission of nephrotic syndrome in patient on long-term simvastatin. Lancet (1990) 1.71
A heritable syndrome of craniosynostosis, short thin hair, dental abnormalities, and short limbs: cranioectodermal dysplasia. J Pediatr (1977) 1.71
Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes (1996) 1.61
Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther (2000) 1.59
Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem (1993) 1.57
Diurnal triglyceride profiles in healthy normolipidemic male subjects are associated to insulin sensitivity, body composition and diet. Eur J Clin Invest (2000) 1.56
[A Dutch family with familial Mediterranean fever]. Ned Tijdschr Geneeskd (1993) 1.49
Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects. Eur J Clin Invest (1998) 1.48
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr (1996) 1.47
Thermal discrimination thresholds in normal subjects and in patients with diabetic neuropathy. J Neurol Neurosurg Psychiatry (1985) 1.43
Smoking and diabetes mellitus. Neth J Med (1996) 1.42
Italian BiodivYsio open registry (BiodivYsio PC-coated stent): study of clinical outcomes of the implant of a PC-coated coronary stent. J Invasive Cardiol (2000) 1.41
Relationship between peripheral vascular disease and high plantar pressures in diabetic neuro-ischaemic patients. Diabetes Metab (2003) 1.41
Islet-amyloid polypeptide in human plasma. Lancet (1990) 1.40
[Triglycerides and atherosclerosis; treatment of hypertriglyceridemia]. Ned Tijdschr Geneeskd (1994) 1.39
Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting. Catheter Cardiovasc Interv (2005) 1.39
Energy expenditure and substrates oxidative patterns, after glucose, fat or mixed load in normal weight subjects. Eur J Clin Nutr (1997) 1.39
[Decrease in coronary heart disease mortality in 1974-1992 largely explainable by changes in cholesterol and smoking risk factors]. Ned Tijdschr Geneeskd (1995) 1.39
Danaparoid: an antithrombotic agent without major impact on triglyceride hydrolysis capacity in humans. J Intern Med (1997) 1.38
Epidemiology of reflex syncope. Clin Auton Res (2004) 1.37
Pathways from obesity to diabetes. Int J Obes Relat Metab Disord (2002) 1.36
Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in The Netherlands. Diabetes Res Clin Pract (1991) 1.33
Fluid endocytosis in isolated rat parenchymal and non-parenchymal liver cells. Exp Cell Res (1980) 1.33
Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care. Clin Infect Dis (2008) 1.29
Appraisal of computerized medical histories: comparisons between computerized and conventional records. Comput Biomed Res (1986) 1.26
Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1987) 1.24
Glucose-induced thermogenesis in nondiabetic and diabetic obese subjects. Diabetes (1982) 1.23
Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency. J Clin Endocrinol Metab (2000) 1.19
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol (1996) 1.19
Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes. Am J Med Genet (1983) 1.18
Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med (2004) 1.17
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta (1995) 1.16
Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care (1996) 1.16
Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J (1994) 1.15
SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med (2012) 1.14
Gait characteristics of diabetic patients: a systematic review. Diabetes Metab Res Rev (2008) 1.13
Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet (1997) 1.13
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia (2011) 1.13
Effects of physical training on metabolic control in elderly type 2 diabetes mellitus patients. Clin Sci (Lond) (1997) 1.13
Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol (1996) 1.10
Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice. Am J Cardiol (2000) 1.10
Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care (1998) 1.10
Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I. Am J Cardiol (1999) 1.10
Randomised controlled trial of a guided self-help treatment on the Internet for binge eating disorder. Behav Res Ther (2011) 1.09
Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res (1989) 1.09
Apolipoprotein concentrations during treatment and recurrent coronary artery disease events. Arterioscler Thromb Vasc Biol (2000) 1.09
Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost (2000) 1.08
The gait and balance of patients with diabetes can be improved: a randomised controlled trial. Diabetologia (2009) 1.08
Fine mapping of a gene responsible for regulating dietary cholesterol absorption; founder effects underlie cases of phytosterolaemia in multiple communities. Eur J Hum Genet (2001) 1.07
"Dynamic imaging" (systolic compression) of myocardial bridge visualised by electronic beam computed tomography. Heart (2007) 1.07
Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care (2000) 1.06
Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia. Lancet (1986) 1.06
Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes (1976) 1.06
Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest (2000) 1.05
Asymptomatic bacteriuria in diabetes mellitus. N Engl J Med (1967) 1.05
Neonatal screening for hyperlipidaemia. Postgrad Med J (1975) 1.05
Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab (1986) 1.02
Changes in membrane lipid composition of human erythrocytes after dietary supplementation of (n-3) polyunsaturated fatty acids. Maintenance of membrane fluidity. Biochim Biophys Acta (1986) 1.01
Energy economy hampers body weight loss after gastric bypass. J Clin Endocrinol Metab (2000) 1.01
Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism (1990) 1.01
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci U S A (1988) 1.00
Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arterioscler Thromb Vasc Biol (2001) 1.00
Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain (1999) 1.00
Determination of cardiac output during mechanical ventilation by electrical bioimpedance or thermodilution in patients with acute lung injury: effects of positive end-expiratory pressure. Crit Care Med (1998) 1.00
[Attitude of Swiss Army recruits from Tessin to pain and euthanasia (1992 and 1995)]. Schweiz Med Wochenschr (1996) 1.00
Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Data from the GISSI-2 database. Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). Arch Intern Med (1997) 0.99
Postoperative evaluation of myocardial blood flow in aorta-to-coronary artery vein bypass grafts using the xenon-residue detection technic. Circulation (1972) 0.99
Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia. J Clin Invest (1986) 0.99
Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism (1987) 0.99
Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res (1987) 0.98
Metabolic normality in overweight and obese subjects. Which parameters? Which risks? Int J Obes (Lond) (2011) 0.98
Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia (1987) 0.98
Factors influencing energy intake and body weight loss after gastric bypass. Eur J Clin Nutr (2002) 0.98
Reproducibility and validity of a short food questionnaire for the assessment of dietary habits. Nutr Metab Cardiovasc Dis (2002) 0.97
Phytosterolaemia in a Norwegian family: diagnosis and characterization of the first Scandinavian case. Scand J Clin Lab Invest (1996) 0.97
[Sense and nonsense in the diagnosis of spontaneous hypoglycemia]. Ned Tijdschr Geneeskd (1989) 0.97
Fasting and daylong triglycerides in obesity with and without type 2 diabetes. Metabolism (2003) 0.96
Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes (1990) 0.96
Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metab (1986) 0.96
Evaluation of a guided internet self-treatment programme for bulimia nervosa in several European countries. Eur Eat Disord Rev (2010) 0.95
C-peptide. Diabetes Care (1983) 0.95